| Home | E-Submission | Sitemap | Editorial Office |  
J Korean Wound Management Soc > Volume 4(1); 2008 > Article
Journal of the Korean Wound Management Society 2008;4(1): 16-19.
수술적 치료가 불가능한 당뇨발 환자에서 표피성장인자의 효능 및 올바른 치료 접근 방법
1서울아산병원 성형외과, 2울산대학교 의과대학 성형외과학교실
Using Recombinant Human Epidermal Growth Factor with Standard of Good Care for Diabetic Foot Ulcers in Inoperable Patients
Hyo Bo Lee1, Joon Pio Hong2
1Department of Plastic Surgery, Asan Medical Center, Seoul, Korea, 2School of Plastic Surgery, College of Medicine, Ulsan University, Ulsan, Korea
  Published online: 31 May 2008.
To study the healing effect of epidermal growth factor on diabetic ulcers with Mitochondria Encephalopathy Lactic Acidosis Syndrome (MELAS) resistant to standard care. When the standard care alone was not sufficient for a patient suffering from diabetic foot ulcer, epidermal growth factor (Easyef, DaeWoong Pharm. Seoul, Korea) was added to the protocol. The wound was monitored for 10 weeks. A 46-year-old man with 15 year history for type 2 diabetes mellitus and Mitochondria Encephalopathy Lactic Acidosis Syndrome (MELAS) presented with 2 chronic foot ulcers (3×3 cm, 3×3.4 cm). Prior to the study, the patient was treated with standard care using advanced dressings, off-loading, and hyperbaric oxygen therapy for 12 weeks but failed to achieve improvement. Along with good standard care, Easyef(DaeWoong Pharm. Seoul, Korea) was added to the regimen and both ulcers achieved wound closure within 10 and 7 weeks. Good standard of care for diabetic foot ulceration includes glycemic control, off loading, good nutrition, wound management and education. Chronic wound environment frequently with depleted growth factors can prevent the wound from healing despite of good care. Recombinant human Epidermal growth factor (rh-EGF) can play a role in healing by augmenting cell proliferation, migration and differentiation on target cells. This study reports such a case with successful use of rh-EGF. (J Korean Wound Management Soc 2008;4:16-19)
Key Words: EGF, Diabetic ulceration, MELAS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
CrossRef TDM  CrossRef TDM
Related article
Editorial Office
Department of Plastic & Reconstructive Surgery, Dankook University Hospital
201 Manghyang-ro, Dongnam-gu, Cheonan 31116, Korea
TEL: +82-41-550-6285   FAX: +82-41-556-0524   E-mail: office@jwmr.org
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Wound Management Society. All rights reserved.                 Developed in M2community
Close layer
prev next